Corporate Cannabis
The pharmaceutical industry's surprising new cash crop
May / June 2005
Barb Jacobs Utne magazine
In the 1938 propaganda film Reefer Madness, teens who
dare take a toke of the demon weed (also known as marijuana) are
reduced to cackling maniacs obsessed with evil jazz music, bent on
homicide, and destined for the loony bin. Today, the faux
documentary is celebrated as a kitschy cult classic. Yet the film's
central message is in lockstep with the Bush administration's war
on drugs.
RELATED ARTICLES
It has no conscience. It's pathological. And it's in your neighborhood....
Stopping Corporate Interference in Local Government January 13, 2003 Issue By Erica Sagrans, Utne....
Corporate Blind-Eye to King Holiday January 12, 2001 Leif Utne Corporate Blind-Eye to King...
Shareholders Unite The past year has seen unprecedented efforts by shareholders to hold their compa...
Asserting Democratic Control of Food and Agriculture June 28, 2002 Issue By Julie Madsen Asserting...
While the federal government continues to use the courts to wage
an aggressive campaign against the medicinal use of marijuana in
California and other states where it's legal (frequently relying on
alarmist rhetoric reminiscent of the aforementioned film),
forward-thinking industrialists in Europe have been developing
alternative ways to deliver pain relief to the sick and dying.
The ingredient in marijuana that makes people high is delta
9-tetrahydrocannabinol, or THC. Combined with the other naturally
occurring chemicals in marijuana, it can also be used to alleviate
a host of maladies, including the nausea associated with
chemotherapy, muscle spasms caused by multiple sclerosis, internal
eye pressure from glaucoma, and the appetite loss that often
accompanies AIDS.
The Drug Enforcement Administration (DEA) has long maintained
that legalizing medicinal marijuana would lead to higher rates of
addiction and increased criminal activity, a position that Dr.
Jerome Kassirer, editor of the New England Journal of
Medicine, calls 'misguided, heavy-handed, and inhumane.' Other
advocates for medicinal marijuana simply believe that America's
resistance to change is based on fear of getting high.
In an effort to appease American euphoriphobia -- and turn a
healthy profit elsewhere -- the British company GW Pharmaceuticals
has developed a cannabis-based spray. According to the
Toronto-based magazine The Walrus (Feb. 2005),
users are promised all the medicinal benefits of marijuana without
the cancerous smoke and tar. The company has also developed a
tamper-proof inhaler that prevents abuse of the substance. A doctor
simply keys in the allowable dose -- enough to relieve chronic
pain, but not enough to get the user stoned -- and any attempt to
sneak a little more results in a cutoff.